Advertisement

Topics

Embattled Teva slashes staff, manufacturing facilities

09:49 EDT 3 Aug 2017 | BioPharmaDive

Lower-than-expected revenues in the second quarter, due to greater pressure on generics, is pushing the Israeli company to look at cost-cutting measures. 

Original Article: Embattled Teva slashes staff, manufacturing facilities

NEXT ARTICLE

More From BioPortfolio on "Embattled Teva slashes staff, manufacturing facilities"

Quick Search
Advertisement